I Sens Inc
KOSDAQ:099190
Net Margin
I Sens Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
KR |
I
|
I Sens Inc
KOSDAQ:099190
|
457.7B KRW |
0%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
234.1B USD |
32%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
187.7B USD |
28%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
146.4B USD |
12%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
147.5B USD |
12%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
113.3B USD |
14%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
52.5B EUR |
9%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
49.7B USD |
7%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
44.7B USD |
75%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.4B USD |
23%
|
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
287.7B CNY |
31%
|
I Sens Inc
Glance View
i-SENS, Inc. engages in development and manufacture of medical, environmental, industrial sensors. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-01-30. The Company’s products consist of blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others; electrolyte analyzers and cartridges; immunosensors, as well as other related accessories, such as connectors, lancets, blood glucose data management software and lancing devices, among others. The firm distributes its products within domestic market and to overseas markets including Japan, Europe, the United States and others.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on I Sens Inc's most recent financial statements, the company has Net Margin of 0.4%.